Ocugen (OCGN) Preferred Dividend Payments (2016 - 2020)
Ocugen (OCGN) reported Preferred Dividend Payments of $12.5 million for Q2 2020, up 59842.86% quarter-over-quarter from -$21000.0 in Q1 2019.
Ocugen (OCGN) Preferred Dividend Payments (2016 - 2020) Analysis & Trends
Ocugen has reported Preferred Dividend Payments for 5 years, with the latest figure at $12.5 million in Q2 2020.
- For the quarter ending Q2 2020, Preferred Dividend Payments changed N/A year-over-year to $12.5 million; the trailing twelve-month figure through Jun 2021 stood at $12.5 million (changed 0.0% YoY), and the FY2020 full-year result was $12.5 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q2 2020 stood at $12.5 million, up from -$21000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $12.5 million in Q2 2020, with the low at -$1.2 million in Q1 2017.
- Historically, Preferred Dividend Payments has averaged $1.2 million across 5 years, with a median of -$463000.0 in 2018.
- Annual changes were most pronounced in 2017 — Preferred Dividend Payments plunged 1029.63% — and 2019, when it soared 95.46%.
- Ocugen's Preferred Dividend Payments stood at -$81000.0 in 2016, then sank by 1029.63% to -$915000.0 in 2017, then jumped by 49.4% to -$463000.0 in 2018, then soared by 95.46% to -$21000.0 in 2019, then surged by 59842.86% to $12.5 million in 2020.
- The last three Preferred Dividend Payments figures came in at $12.5 million (Q2 2020), -$21000.0 (Q1 2019), and -$463000.0 (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 12.55 Mn |
| Mar 31, 2019 | -21,000.00 |
| Mar 31, 2018 | -463,000.00 |
| Sep 30, 2017 | -915,000.00 |
| Jun 30, 2017 | -1.09 Mn |
| Mar 31, 2017 | -1.25 Mn |
| Sep 30, 2016 | -81,000.00 |